MedTrace Logo

Disease Containment Measures Among Older Adults During the Covid-19 Pandemia

NCT04792086 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 12000

Last updated 2024-03-21

No results posted yet for this study

Summary

This study will examine which impact lockdown strategies intending to prevent the spread of COVID-19 had on people with cognitive impairment and dementia.

Comprehensive data from two large health studies in Norway, conducted before and after the COVID-19 outbreak, will be linked with health register data on the use of health care services and medication. Further, it will be conducted a survey addressing questions on social isolation and use of communicative technology, from March 2020 to January 2021. The knowledge gained from this study can improve the health care system's ability to respond more adequately to pandemics and other unforeseen events, so that the negative consequences for older adults with dementia and cognitive impairment can be reduced.

Conditions

Sponsors & Collaborators

  • Norwegian Centre for Ageing and Health

    lead OTHER

Principal Investigators

  • Geir Selbaek, PhD · Norwegian National Advisory Unit on Ageing and Health

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-18
Primary Completion
2024-03-20
Completion
2025-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04792086 on ClinicalTrials.gov